Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Vincent Heppt

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Pigment Cell & Melanoma Research|December 4, 2018
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasionSaskia Anna Graf, Markus Vincent Heppt, Anja Wessely, et al.
JMIR Mhealth and Uhealth|November 10, 2020
Patient Perception of Mobile Phone Apps for the Care and Prevention of Sexually Transmitted Diseases: Cross-Sectional StudyLena Jakob, Theresa Steeb, Zeno Fiocco, et al.
Journal for Immunotherapy of Cancer|May 9, 2024
Gene network-based and ensemble modeling-based selection of tumor-associated antigens with a predicted low risk of tissue damage for targeted immunotherapyChristopher Lischer, Martin Eberhardt, Cindy Flamann, et al.
Journal for Immunotherapy of Cancer|May 19, 2023
Bispecific antibodies redirect synthetic agonistic receptor modified T cells against melanomaFlorian Märkl, Mohamed-Reda Benmebarek, Julius Keyl, et al.
Journal for Immunotherapy of Cancer|March 5, 2026
Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review studyElizabeth M Gaughan, Miso Kim, Ignacio Mendez, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 26, 2022
Real-world outcomes using PD-1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and SwitzerlandKatharina Schumann, Cornelia Mauch, Kai-Christian Klespe, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Pigment Cell & Melanoma Research|December 4, 2018
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasionSaskia Anna Graf, Markus Vincent Heppt, Anja Wessely, et al.
JMIR Mhealth and Uhealth|November 10, 2020
Patient Perception of Mobile Phone Apps for the Care and Prevention of Sexually Transmitted Diseases: Cross-Sectional StudyLena Jakob, Theresa Steeb, Zeno Fiocco, et al.
Journal for Immunotherapy of Cancer|May 9, 2024
Gene network-based and ensemble modeling-based selection of tumor-associated antigens with a predicted low risk of tissue damage for targeted immunotherapyChristopher Lischer, Martin Eberhardt, Cindy Flamann, et al.
Journal for Immunotherapy of Cancer|May 19, 2023
Bispecific antibodies redirect synthetic agonistic receptor modified T cells against melanomaFlorian Märkl, Mohamed-Reda Benmebarek, Julius Keyl, et al.
Journal for Immunotherapy of Cancer|March 5, 2026
Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review studyElizabeth M Gaughan, Miso Kim, Ignacio Mendez, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 26, 2022
Real-world outcomes using PD-1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and SwitzerlandKatharina Schumann, Cornelia Mauch, Kai-Christian Klespe, et al.
Pageof 2